Delphi advisor to Navamedic ASA in connection with the acquisition of Observe Medical International AB and its subsidiaries

Delphi has been legal advisor to Navamedic ASA (”Navamedic”), a company listed on the Oslo Stock Exchange, in the acquisition of the Swedish medical device company Observe Medical International AB (”OM”) from a group of investors led by the Danish venture fund Seed Capital and the founders of OM. The initial purchase price is NOK 35 million, of which NOK 20 million shall be paid in cash and NOK 10 million will be paid through the issue of new Navamedic shares. In addition, there is a possibility to receive certain milestone payments and royalties.